Cantor Fitzgerald came out and expressed concerns around the Magnificent Seven group, saying the stocks are “vulnerable,” suggesting that there could be a shift in fund flows towards different ...

Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data ...

In a report released yesterday, Troy Jensen from Cantor Fitzgerald reiterated a Buy rating on Proto Labs (PRLB – Research Report), with a price target of $50.00. The company’s shares closed ...

(NYSE:ONTO – Free Report) – Equities researchers at Cantor Fitzgerald dropped their FY2025 ... The firm has a 50 day moving average of $186.01 and a 200-day moving average of $190.03.

Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...

The information was expected to be officially published on February 13, coinciding with the day set for the release and oral presentation of the mevrometostat late breaker abstract. The analyst from ...

We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at where AST SpaceMobile, Inc. (NASDAQ:ASTS) stands against other ...

Cantor Fitzgerald started coverage on shares of Amentum ... a current ratio of 1.59 and a debt-to-equity ratio of 1.02. The stock’s 50 day moving average is $21.98. Amentum (NYSE:AMTM ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...